Regional Covid-19 Resources and On Reserve Stats by Region Below - Black = Cases, Green = Recovered, Red = Deaths - Updated Daily
BC
107 | 02 | 30
AB
226 | 01 | 53
SK
95 | 04 | 00
MB
03 | 00 | 00
ON
65 | 02 | 22
QC
45 | 01 | 44
ATL
00 | 00 | 00
YT
00 | 00 | 00
NWT
00 | 00 | 02
 

Widgetized Section

Go to Admin » Appearance » Widgets » and move Gabfire Widget: Social into that MastheadOverlay zone

Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort

April 10, 2012

Travis B. Murdoch, Charles N. Bernstein, Hani El-Gabalawy, Joanne M. Stempak, Michael Sargent, Brenda Elias, Wei Xu, Saad Pathan, Mark S. Silverberg

From the Inflammatory Bowel Disease Group (Murdoch, Stempak, Pathan, Silverberg), Mount Sinai Hospital, University of Toronto, Toronto, Ont.; the Inflammatory Bowel Disease Clinical and Research Centre (Bernstein, Sargent), University of Manitoba, Winnipeg, Man.; the Manitoba First Nations Centre for Aboriginal Health Research (El-Gabalawy, Elias), University of Manitoba, Winnipeg, Man.; and the Dalla Lana School of Public Health (Xu), University of Toronto, Toronto, Ont.
Dr. Mark S. Silverberg, E-mail [email protected]
Abstract

Background: Inflammatory bowel disease is the result of both genes and environment. Canadian First Nations people, despite living in a region with a high prevalence of inflammatory bowel disease, are relatively protected from this disease. We aimed to compare the carriage of genetic variants associated with inflammatory bowel disease in healthy First Nations and white people.Methods: DNA was extracted from the venous blood of healthy First Nations (n = 340) and white (n = 285) participants from Manitoba. Genotyping was performed for 69 single nucleotide polymorphisms (SNPs) with known or suspected associations with inflammatory bowel disease. We compared the genotypes between groups by logistic regression, adjusting for multiple testing. We calculated a risk score for the NOD2 gene by adding the number of risk alleles at three important NOD2 SNPs (G908R, R702W and 3020insC).

Results: We found genetic variation between white and First Nations participants at 45 of 69 SNPs. Notably, carriage of the ATG16L1 T300A mutation was lower in First Nations participants (p = 4.1 W 10-30). Cumulative carriage of important NOD2 variants was significantly lower among First Nations participants (3.9% v. 15.2%; p < 0.0001 for risk score) than among white participants. Risk variants in IL23R (p = 0.014) and IL12B (p = 1.2 W 10-16), among others, were more prevalent among First Nations participants than among white participants.

Interpretation: The low prevalence of variants associated with bacterial processing and handling in First Nations people may explain their relative protection from inflammatory bowel disease. Increased carriage of a number of risk variants, for example in the interleukin-23/Th17 pathway, is especially intriguing given their importance in other inflammatory diseases of high incidence in First Nations populations.